Verve Therapeutics Announces Updates on its PCSK9 Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. ANT
3. SPY
4. FFAI
5. FFR
6. META
7. FICO
8. CART
9. LLY
10. TSLA

Go back to Verve Therapeutics Announces Updates on its PCSK9 Program

Verve Therapeutics (VERV) PT Lowered to $30 at BMO Capital

April 3, 2024 7:43 AM EDT

BMO Capital analyst Kostas Biliouris lowered the price target on Verve Therapeutics (NASDAQ: VERV) to $30.00 (from $56.00) while maintaining a Outperform rating.

The analyst commented, "Management will prioritize VERVE-102 due to a Gr3 AE under 0.45mpk VERVE-101. We believe the durable (>270d) and... More

Verve Therapeutics (VERV) PT Lowered to $40 at Stifel

April 2, 2024 4:52 PM EDT

Stifel analyst Dae Gon Ha lowered the price target on Verve Therapeutics (NASDAQ: VERV) to $40.00 (from $56.00) while maintaining a Buy rating.

The analyst comments "Shares are sharply lower following an earlier VERVE-101 update (LINK) likely amplified by the small dataset backing the... More